Aptose Biosciences Inc
NASDAQ:APTO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Aptose Biosciences Inc
NASDAQ:APTO
|
CA |
|
Ardmore Shipping Corp
NYSE:ASC
|
BM |
|
Amerigo Resources Ltd
TSX:ARG
|
CA |
|
Fox Factory Holding Corp
NASDAQ:FOXF
|
US |
|
Eni SpA
MIL:ENI
|
IT |
|
M
|
Motus Holdings Ltd
JSE:MTH
|
ZA |
|
AnaptysBio Inc
NASDAQ:ANAB
|
US |
|
Consolidated Edison Inc
NYSE:ED
|
US |
|
Babcock & Wilcox Enterprises Inc
NYSE:BW
|
US |
|
Tetra Tech Inc
NASDAQ:TTEK
|
US |
|
Margaret Lake Diamonds Inc
OTC:KNXFF
|
CA |
|
Novo Nordisk A/S
NYSE:NVO
|
DK |
|
Paychex Inc
NASDAQ:PAYX
|
US |
|
ARC Resources Ltd
TSX:ARX
|
CA |
|
Gecina SA
OTC:GECFF
|
FR |
|
S
|
Somboon Advance Technology PCL
SET:SAT
|
TH |
|
AirIQ Inc
XTSX:IQ
|
CA |
|
I
|
Intrum AB
F:IJU
|
SE |
|
Rentokil Initial PLC
LSE:RTO
|
UK |
|
C
|
Compagnie d'entreprises CFE SA
XBRU:CFEB
|
BE |
|
BioNTech SE
NASDAQ:BNTX
|
DE |
|
B
|
Beneficient
NASDAQ:BENF
|
US |
Bankruptcy Probability
Aptose Biosciences Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Aptose Biosciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
A
|
Aptose Biosciences Inc
NASDAQ:APTO
|
5.1m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
376.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
181.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
67.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Aptose Biosciences Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Aptose Biosciences Inc has total debt of 10m USD. This includes both short-term (0 USD) and long-term (10m USD) debt.
You can find a full breakdown on its Balance Sheet.
